CN103270170A - Hla-dqb1基因分型的方法及其相关引物 - Google Patents
Hla-dqb1基因分型的方法及其相关引物 Download PDFInfo
- Publication number
- CN103270170A CN103270170A CN2010800708195A CN201080070819A CN103270170A CN 103270170 A CN103270170 A CN 103270170A CN 2010800708195 A CN2010800708195 A CN 2010800708195A CN 201080070819 A CN201080070819 A CN 201080070819A CN 103270170 A CN103270170 A CN 103270170A
- Authority
- CN
- China
- Prior art keywords
- dqb1
- hla
- seq
- pcr
- primer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (1)
- 权 利 要 求 书1. 具有 SEQ ID NO: 1至 SEQ ID NO: 4任一项所示序列的多核 苷酸。2. 一种 HLA-DQB1的 2和 /或 3号外显子扩增方法, 其特征在 于使用 SEQ ID NO: 1和 SEQ ID NO: 2; 以及 /或者 SEQ ID NO: 3和 SEQ ID NO: 4的引物对进行 PCR扩增。3. 一种对样品中 HLA-DQB1的 2和 /或 3号外显子进行测序的 方法, 其包括步骤:1 ) 提供一个样品并提取该样品的 DNA;2 ) 将 SEQ ID NO: 1和 SEQ ID NO: 2; 以及 /或者 SEQ ID NO: 3和 SEQ ID NO: 4的引物对用于扩增所述 DNA从而得到 PCR产物, 优选对 PCR产物进行纯化;3 ) 对所述 PCR产物进行测序。4. 权利要求 3的方法, 其中所述样品是血样。5. 权利要求 4的方法, 其中所述血样来自哺乳动物或人。6. 一种 HLA-DQB1基因分型方法, 所述方法包括:1)使用 SEQ ID NO: 1和 SEQ ID NO: 2; 以及 /或者 SEQ ID NO: 3和 SEQ ID NO: 4的引物对进行 PCR扩增, 扩增待测样本的HLA-DQB1的 2和 /或 3号外显子;2)对扩增出的外显子进行测序, 并将测序结果与数据库中的标准 序列进行比较, 从而确定基因分型结果。7. 权利要求 3或 6的方法, 其中所述测序是通过 Sanger测序法 或第二代测序法。8. 权利要求 7的方法, 其中所述第二代测序方法是 Illumina Solexa或 Roche454。9. 一种用于进行 HLA-DQB1基因分型的试剂盒, 所述试剂盒中 包括 SEQ ID NO: 1和 SEQ ID NO: 2; 以及 /或者 SEQ ID NO: 3和 SEQ ID NO: 4的引物对,所述试剂盒优选还包含用于 DNA扩增、 DNA 纯化和 /或 DNA测序的试剂。10. 权利要求 1的多核苷酸、 权利要求 6的方法或权利要求 9的试 剂盒用于 HLA- DQB1基因分型的用途。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2010/002150 WO2012083506A1 (zh) | 2010-12-24 | 2010-12-24 | Hla-dqb1基因分型的方法及其相关引物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103270170A true CN103270170A (zh) | 2013-08-28 |
CN103270170B CN103270170B (zh) | 2015-07-29 |
Family
ID=46313007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201080070819.5A Active CN103270170B (zh) | 2010-12-24 | 2010-12-24 | Hla-dqb1基因分型的方法及其相关引物 |
Country Status (4)
Country | Link |
---|---|
CN (1) | CN103270170B (zh) |
HK (1) | HK1185115A1 (zh) |
TW (1) | TW201300528A (zh) |
WO (1) | WO2012083506A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109371114A (zh) * | 2018-12-26 | 2019-02-22 | 银丰基因科技有限公司 | Hla-dqb1基因分型试剂盒 |
CN111560430A (zh) * | 2020-06-17 | 2020-08-21 | 中南大学湘雅二医院 | 检测rs1766位点多态性的试剂及其应用 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106795650B (zh) * | 2014-09-26 | 2021-03-09 | 深圳华大基因股份有限公司 | Pf快速建库方法及其应用 |
CN106978484A (zh) * | 2017-03-16 | 2017-07-25 | 北京博奥晶典生物技术有限公司 | 通过pcr添加剂解决等位基因扩增不平衡的方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100261189A1 (en) * | 2008-10-03 | 2010-10-14 | Roche Molecular Systems, Inc. | System and method for detection of HLA Variants |
CN101921842A (zh) * | 2010-06-30 | 2010-12-22 | 深圳华大基因科技有限公司 | Hla-a,b基因分型用pcr引物及其使用方法 |
CN101962676A (zh) * | 2010-08-31 | 2011-02-02 | 深圳市血液中心 | 人类白细胞抗原hla-a、b基因全长序列测定以及hla基因测序分型方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2101083T3 (es) * | 1990-12-21 | 1997-07-01 | Hoffmann La Roche | Tipado del dna hla dqbeta. |
CN101654691B (zh) * | 2009-09-23 | 2013-12-04 | 深圳华大基因健康科技有限公司 | Hla基因扩增和基因分型方法及其相关引物 |
CN101921841B (zh) * | 2010-06-30 | 2014-03-12 | 深圳华大基因科技有限公司 | 基于Illumina GA测序技术的HLA基因高分辨率分型方法 |
CN101921840B (zh) * | 2010-06-30 | 2014-06-25 | 深圳华大基因科技有限公司 | 一种基于dna分子标签技术和dna不完全打断策略的pcr测序方法 |
-
2010
- 2010-12-24 WO PCT/CN2010/002150 patent/WO2012083506A1/zh active Application Filing
- 2010-12-24 CN CN201080070819.5A patent/CN103270170B/zh active Active
-
2011
- 2011-12-23 TW TW100148364A patent/TW201300528A/zh unknown
-
2013
- 2013-11-11 HK HK13112600.2A patent/HK1185115A1/zh unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100261189A1 (en) * | 2008-10-03 | 2010-10-14 | Roche Molecular Systems, Inc. | System and method for detection of HLA Variants |
CN101921842A (zh) * | 2010-06-30 | 2010-12-22 | 深圳华大基因科技有限公司 | Hla-a,b基因分型用pcr引物及其使用方法 |
CN101962676A (zh) * | 2010-08-31 | 2011-02-02 | 深圳市血液中心 | 人类白细胞抗原hla-a、b基因全长序列测定以及hla基因测序分型方法 |
Non-Patent Citations (2)
Title |
---|
《Human Immunology》 19990930 Myoung Hee Park et al. "High resolution HLA-DQB1 typing by combination of PCR-RFLP and PCR-SSCP" 第60卷, 第9期 * |
MYOUNG HEE PARK ET AL.: ""High resolution HLA-DQB1 typing by combination of PCR-RFLP and PCR-SSCP"", 《HUMAN IMMUNOLOGY》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109371114A (zh) * | 2018-12-26 | 2019-02-22 | 银丰基因科技有限公司 | Hla-dqb1基因分型试剂盒 |
CN111560430A (zh) * | 2020-06-17 | 2020-08-21 | 中南大学湘雅二医院 | 检测rs1766位点多态性的试剂及其应用 |
CN111560430B (zh) * | 2020-06-17 | 2023-05-23 | 中南大学湘雅二医院 | 检测rs1766位点多态性的试剂及其应用 |
Also Published As
Publication number | Publication date |
---|---|
TWI461532B (zh) | 2014-11-21 |
CN103270170B (zh) | 2015-07-29 |
HK1185115A1 (zh) | 2014-02-07 |
WO2012083506A1 (zh) | 2012-06-28 |
TW201300528A (zh) | 2013-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2011274090B2 (en) | New PCR sequencing method and use thereof in HLA genotyping | |
CN101921840B (zh) | 一种基于dna分子标签技术和dna不完全打断策略的pcr测序方法 | |
CN101921842B (zh) | Hla-a,b基因分型用pcr引物及其使用方法 | |
CN103270170A (zh) | Hla-dqb1基因分型的方法及其相关引物 | |
JP3384806B2 (ja) | Hla−dr型別判定の実施を可能にするプローブ系および該プローブを用いる型別判定法 | |
AU772175B2 (en) | Method for analysing a patient's genetic predisposition to at least a disease and amplification adapted to such a method | |
Latham et al. | An overview of HLA typing for hematopoietic stem cell transplantation | |
Dunn | Novel approaches and technologies in molecular HLA typing | |
JP2016516449A (ja) | Hlaマーカーを使用する母体血液中の胎児dna分率の決定方法 | |
CN108441547B (zh) | 一种hla基因扩增、基因分型的引物组、试剂盒和方法 | |
EP2186911A1 (en) | A method for determining the Histocompatibility Locus Antigen Class II | |
CN103261438B (zh) | Hla-c基因分型的方法及其相关引物 | |
EP0887423A1 (en) | A method for determining the Histocompatibility locus antigen class II | |
Han et al. | Multiplex single nucleotide extension: a robust and high throughput method for HLA-A locus typing | |
Kuhn et al. | Use of capillary array electrophoresis single-strand conformational polymorphism analysis to estimate genetic diversity of candidate genes in germplasm collections | |
US20040038258A1 (en) | Methods for detecting DNA polymorphisms | |
CN116574791A (zh) | 一种快速hla测序分型组合试剂盒及分析方法 | |
CN113957141A (zh) | 检测与高血压相关基因scnn1b突变的寡核苷酸和其应用 | |
CN115354072A (zh) | 一种用于hla-dqa1基因分型的引物组和分析方法 | |
JP2011050377A (ja) | 新規hla−drb1遺伝子およびその用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: SHENZHEN BEIJING GENOMICS INSTITUTE HEALTH TECHNOL Free format text: FORMER OWNER: BGI-SHENZHEN CO., LTD. Effective date: 20130903 |
|
C10 | Entry into substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20130903 Address after: Yantian District of Shenzhen City, Guangdong province 518083 North Road No. 146 North Industrial Zone 11, floor 3, 2 Applicant after: Shenzhen Huada Gene Health Technology Co., Ltd. Address before: 11, 8 floor, Beishan Industrial Zone, Yantian District, Guangdong, Shenzhen 518083, China Applicant before: BGI-Shenzhen Co., Ltd. |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1185115 Country of ref document: HK |
|
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: Yantian District of Shenzhen City, Guangdong province 518083 North Road No. 146 North Industrial Zone 11, floor 3, 2 Applicant after: Shenzhen BGI Medicine Co., Ltd. Address before: Yantian District of Shenzhen City, Guangdong province 518083 North Road No. 146 North Industrial Zone 11, floor 3, 2 Applicant before: Shenzhen Huada Gene Health Technology Co., Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: SHENZHEN BEIJING GENOMICS INSTITUTE HEALTH TECHNOLOGY CO., LTD. TO: SHENZHEN BGI MEDICINE CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHENZHEN BGI CORPORATION Free format text: FORMER OWNER: SHENZHEN BGI MEDICINE CO., LTD. Effective date: 20150729 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150729 Address after: Yantian District of Shenzhen City, Guangdong province 518083 Hongan street No. 21 China Comprehensive Park 7 Building 7 layer -14 layer Patentee after: BGI SHENZHEN CO LTD Address before: Yantian District of Shenzhen City, Guangdong province 518083 North Road No. 146 North Industrial Zone 11, floor 3, 2 Patentee before: Shenzhen BGI Medicine Co., Ltd. |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1185115 Country of ref document: HK |